Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Revenue (LTM)
$0
Net Income (LTM)
$-446M
-40.6% YoY
Free Cash Flow
$-405M
Revenue CAGR (5Y)
Marginsstable
|
FCF($0.4B)
|
Unprofitable

Income Statement

MetricDec 21Dec 22Dec 23
Revenue
0
0
0
Gross Profit
0
0
-2
Operating Income
-150
-171
-242
Net Income
-149
-168
-236
EBITDA
-149
-169
-233
EPS Diluted
-2.93
-3.23
-3.95

Balance Sheet

MetricDec 21Dec 22Dec 23
Cash & Equivalents
201
172
122
Total Current Assets
382
266
129
Total Assets
426
306
165
Total Current Liabilities
29
28
51
Total Liabilities
57
54
74
Total Equity
368
252
91
Total Debt
33
30
27
Net Debt
-168
-142
-94

Cash Flow Statement

MetricDec 21Dec 22Dec 23
Operating Cash Flow
-120
-154
-188
Capital Expenditure
-4
-3
-1
Free Cash Flow
-123
-157
-189
Stock-Based Comp
18
15
20
Net Change in Cash
-100
-29
-51
Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down